Farcast
Farcast: A Boston-based clinical diagnostic firm, personalizing cancer treatment through innovative tumor testing.
Founded
2010Farcast: A Boston-based clinical diagnostic firm, personalizing cancer treatment through innovative tumor testing.
Farcast, founded in Boston, Massachusetts, is a clinical diagnostic company dedicated to personalizing cancer treatment. The company's core mission is to illuminate the personal treatment truth of cancer patients by leveraging advanced biological systems that preserve the native contextures of the human tumor microenvironment. Farcast offers services that enable oncologists and drug developers to test individual tumors to determine treatment response profiles. Their market focus includes both clinical diagnostics and pharmaceutical development, with operations extending to a lab in Bangalore, India.
Notable affiliated individuals include leading oncologists and researchers who contribute to the company's innovative approach. Farcast has attracted significant investment from venture capital firms specializing in healthcare technology. Key achievements include the development of their proprietary TruTumor Systems, which capture the heterogeneity in tumor response and resistance, and the generation of high-quality "big data" through orthogonal assays. Farcast's impact lies in its ability to provide personalized treatment insights, potentially improving outcomes for cancer patients worldwide.
Companies similar to Farcast include Mitra Biotech, Empiri, Castle Biosciences and EcoGenome.
Farcast was founded in 2010.
Farcast's headquarters is located in Boston, MA, US.
Farcast's most recent funding round was for $120k (USD) in July 2019.
As of Jul 15, 2019, Farcast has disclosed funding of $74.6M (USD). Undisclosed round amounts are excluded.
Farcast has 75 employees as of Feb 4, 2024.
EcoGenome
ecogenomellc.com
